IRulya Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(C)(4)
IRLA•IRulya Therapeutics announced inducement grants under Nasdaq Listing Rule 5635(C)(4).
1. Inducement grants
IRulya Therapeutics announced inducement grants under Nasdaq Listing Rule 5635(C)(4).
